Tchaikapharma High Quality Medicines AD (BUL:THQM)

Market Cap	1.73B +20.7%
Revenue (ttm)	66.61M +21.4%
Net Income	7.40M +53.4%
EPS	0.08 +54.6%
Shares Out	95.90M
PE Ratio	231.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	9.20
Previous Close	n/a
Day's Range	9.20 - 9.30
52-Week Range	4.67 - 9.55
Beta	0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 28, 2026

About BUL:THQM

Tchaikapharma High Quality Medicines AD develops, manufactures, and sells medicines in Bulgaria. It offers anesthetic, anti-inflammatory and anti-rheumatic, antibiotics, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. The company was founded in 1999 and is headquartered in Sofia, Bulgaria.

• Industry: Pharmaceutical Preparations
• Founded: 1999
• Employees: 214
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: THQM

Financial Performance

In 2025, BUL:THQM's revenue was 32.73 million, an increase of 20.17% compared to the previous year's 27.24 million. Earnings were 3.29 million, an increase of 42.87%.

Financial numbers in EUR